Cargando…

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline

We analyzed 21,676 residual specimens from Ontario, Canada collected between March-August, 2020 to investigate the effect of antibody decline on SARS-CoV-2 seroprevalence estimates. Testing specimens orthogonally using the Abbott (anti-nucleocapsid) and then the Ortho (anti-spike) assays, seropreval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolotin, Shelly, Tran, Vanessa, Osman, Selma, Brown, Kevin A, Buchan, Sarah A, Joh, Eugene, Deeks, Shelley L, Allen, Vanessa G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928877/ https://www.ncbi.nlm.nih.gov/pubmed/33400794 http://dx.doi.org/10.1093/infdis/jiaa796

Ejemplares similares

Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020
por: Bolotin, Shelly, et al.
Publicado: (2021)

Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) study
por: Osman, Selma, et al.
Publicado: (2022)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review
por: Perry, Julie, et al.
Publicado: (2022)

Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT
por: Lutz, Chelsea S., et al.
Publicado: (2023)

Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay
por: Bolotin, Shelly, et al.
Publicado: (2023)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
por: Dobaño, Carlota, et al.
Publicado: (2021)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
por: Rak, Alexandra, et al.
Publicado: (2022)

Development of a Method for Detection of SARS-CoV-2 Nucleocapsid Antibodies on Dried Blood Spot by DELFIA Immunoassay
por: Damiani, Verena, et al.
Publicado: (2023)

Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
por: Søfteland, John M., et al.
Publicado: (2022)

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
por: Lebo, Emmaculate J., et al.
Publicado: (2015)

Comparison of the Seroprevalence of Measles Antibodies among Healthcare Workers in Two Korean Hospitals in 2019
por: Kwak, Yee Gyung, et al.
Publicado: (2020)

Seroprevalence of Plasmodium vivax Circumsporozoite Protein Antibody in High-Risk Malaria Areas in Korea
por: Lee, Jinyoung, et al.
Publicado: (2021)

High Hepatitis E Virus (HEV) Seroprevalence and No Evidence of HEV Viraemia in Vietnamese Blood Donors
por: Cao, Le Chi, et al.
Publicado: (2023)

SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months
por: Kerr, Colm, et al.
Publicado: (2021)

Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron
por: Zhou, Bing, et al.
Publicado: (2022)

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID
por: Brandt, C. T., et al.
Publicado: (2023)

Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
por: Noh, Ji Yun, et al.
Publicado: (2020)

Spatial Owner-Dog Seroprevalence of Leptospira spp. Antibodies in Oceanic Islands and Costal Mainland of Southern Brazil
por: Freitas, Aaronson Ramathan, et al.
Publicado: (2023)

Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study
por: Atkinson, Andrea, et al.
Publicado: (2023)

Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
por: Wilber, Eli, et al.
Publicado: (2022)

Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007–2011
por: Wilson, Sarah E., et al.
Publicado: (2015)

Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity
por: Bolotin, Shelly, et al.
Publicado: (2015)

Population-Level Impact of Ontario’s Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects
por: Wilson, Sarah E., et al.
Publicado: (2016)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
por: Naranbhai, Vivek, et al.
Publicado: (2020)

Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers
por: Cortés-Sarabia, Karen, et al.
Publicado: (2023)

Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji
por: Henderson, Alasdair D, et al.
Publicado: (2020)

Declining seroprevalence of hepatitis A in Vojvodina, Serbia
por: Medić, Snežana, et al.
Publicado: (2019)

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections
por: Grunau, Brian, et al.
Publicado: (2022)

Progressive decline of glucocerebrosidase in aging and Parkinson's disease
por: Rocha, Emily M, et al.
Publicado: (2015)

Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
por: Mullins, Michelle O., et al.
Publicado: (2023)

Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
por: Aguilera, Ximena, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

SARS-Cov-2 seroprevalence and risk factors among health care workers: Estimating the risk of COVID-19 dedicated units
por: Oliveira, Maura Salaroli de, et al.
Publicado: (2021)

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
por: Kagucia, E Wangeci, et al.
Publicado: (2021)

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022
por: García-Sempere, Aníbal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tqce375fpodfab22sbkt3fcdq8